Powered by

The Baden-Württemberg healthcare industry

News from biotechnology, medical technology and pharmaceutical industry

New Dossier

Diagnosing suitable biomarkers is a prerequisite for tailoring personalised therapies to patient heterogeneity. Genetic tests and genome sequencing play a key role in these diagnoses. Up until now, personalised therapy has achieved the greatest success in the field of oncology. However, personalised treatments are also gaining in importance for treating other diseases.

New funding opportunities in our database

Upcoming events

Website address: https://www.gesundheitsindustrie-bw.de/en/